![MEDVANCE_WEBINAIRE_2903 | MEDVANCE Ursula von der Leyen](https://medvance.eu/wp-content/uploads/2022/03/MEDVANCE_WEBINAIRE_2903.png)
DESCRIPTION
Remap Consulting, joined by Paul Miller of NICE, will be reviewing the regulatory and market access impacts of Brexit on a manufacturer’s European launch sequence and will summarise the recent changes at NICE.
The panel will aim to answer these two questions:
- Will it be worth the trouble launching in the UK in five years’ time?
- Should the UK be deprioritised in the launch sequence
INFORMATIONS
Where : Online – Zoom
Date : March 29, 2022 – 9pm (UTC+1)